Page results
-
Media statement UCLH chief executive David Probert said: “Many congratulations to Carrie and Boris Johnson on the birth of their baby daughter Romy Iris Charlotte Johnson. We wish…
-
A huge thank you and well done to everyone who ran the London Marathon last weekend to support UCLH.
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
-
The UCLH and Great Ormond Street Hospital paediatric neuro-oncology service, which treats children with brain cancer, has been designated as one of six new ‘Tessa Jowell Centres of Excellence’.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
A groundbreaking e-learning course dedicated to improving care and understanding of Sickle Cell Disorder (SCD) has been officially launched, marking a significant milestone in the fight against health inequalities.
-
How we use your information at UCLH: what you need to know
-
An international clinical trial testing a novel cancer immunotherapy which may prevent skin cancer from recurring has recruited its first patients at UCLH.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
File results
-
FOI/2024/0143 - Individuals arriving at A&E not in an ambulance
-
FOI/2024/0144 - Breast cancer treatment
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023